Development of the PD GeneChip: a research and diagnostic tool for Parkinson's disease. The PD GeneChip will provide both social and economic benefits to Australia. It will be a key research platform for Australian scientists, and will facilitate collaboration both within Australia and overseas. It will assist with health care management of PD (Parkinson's disease) patients by providing a cost-effective diagnostic tool and the possibility of predicting the clinical course of disease. This inform ....Development of the PD GeneChip: a research and diagnostic tool for Parkinson's disease. The PD GeneChip will provide both social and economic benefits to Australia. It will be a key research platform for Australian scientists, and will facilitate collaboration both within Australia and overseas. It will assist with health care management of PD (Parkinson's disease) patients by providing a cost-effective diagnostic tool and the possibility of predicting the clinical course of disease. This information will provide the basis for tailoring treatment to a patients needs. It is anticipated that marketing of the PD GeneChip within Australia and overseas may produce revenue of at least $40 million annually.Read moreRead less
Prediction of outcome following whiplash injury: a multicentre international prospective study. The main aim of this study is to validate a set of biological and psychological prognostic indicators of outcome following whiplash injury that we have previously identified in a single centre prospective cohort. Validation will be in the context of a large multicentre international cohort. This will allow stakeholders involved in whiplash such as health care and insurance providers to predict with co ....Prediction of outcome following whiplash injury: a multicentre international prospective study. The main aim of this study is to validate a set of biological and psychological prognostic indicators of outcome following whiplash injury that we have previously identified in a single centre prospective cohort. Validation will be in the context of a large multicentre international cohort. This will allow stakeholders involved in whiplash such as health care and insurance providers to predict with confidence both those persons at risk of developing chronic symptoms as well as those with a good chance of full recovery. Furthermore the validation of the predictive capacity of these indicators will, for the first time, provide predictive markers that are amenable to specific early multiprofessional treatment interventions.Read moreRead less